Overview
- 50 inspections across 31 sites are on record.
- 43 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2012-04-12.
At a glance
Inspections
50
Sites
31
Observations
43
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Alza Corporation | 12 Apr 2012 | View 483 → | |
| Mylan Specialty, L.P. | 16 Feb 2012 | ||
| PETNET Solutions, Inc. | 12 Jan 2012 | ||
| Biomarin Pharmaceutical Inc. | 3 Nov 2011 | View 483 → | |
| Genentech, Inc. | 26 Sep 2011 | On file |
Sites inspected
Alza CorporationVacaville, United States1 insp.
Mylan Specialty, L.P.Morgantown, United States1 insp.
PETNET Solutions, Inc.Palo Alto, United States1 insp.
Biomarin Pharmaceutical Inc.Novato, United States1 insp.
Genentech, Inc.South San Francisco, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Henry K Lau3 shared
Peter E Baker2 shared
Lance M De Souza2 shared
Daniel J Roberts2 shared
Mabel M Lee1 shared
William V Millar1 shared
Sangeeta M Khurana1 shared
Thomas W Gordon1 shared
Andrew P Lin1 shared
Italia Nappi1 shared
Full investigator report
Get the verbatim findings behind Jeffrey M Watson's 43 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site